Search Results

Liposomes for Inhalation.

• Authors : Ong HX; Woolcock Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.; Traini D

Subjects: Liposomes*/Liposomes*/Liposomes*/chemistry ; Liposomes*/Liposomes*/Liposomes*/metabolism ; Pneumonia*

• Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2024 Apr; Vol. 37 (2), pp. 100-110.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print Cited

Record details

Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect.

• Authors : Lu X; Department of Chemistry, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.; Cheng H

Subjects: Liposomes* ; Neoplasms*/Neoplasms*/Neoplasms*/pathology; Animals

• Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Oct; Vol. 38 (8), pp. 543-557. Date of Electronic Publication: 2021 Mar 12.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

Exploring the Lipid World Hypothesis: A Novel Scenario of Self-Sustained Darwinian Evolution of the Liposomes.

• Authors : Subbotin V; Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA.; Fiksel G

Subjects: Liposomes* ; RNA, Catalytic*; RNA

• Source: Astrobiology [Astrobiology] 2023 Mar; Vol. 23 (3), pp. 344-357. Date of Electronic Publication: 2023 Jan 30.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101088083 Publication Model: Print-Electronic

Record details

Comparison of Soluble and Liposome Encapsulated, Sustained Release Latanoprost for Focal Adipose Reduction.

• Authors : Loder S; Department of Plastic Surgery and University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Sukinik J

Subjects: Liposomes* ; Desoxycorticosterone Acetate*; Humans

• Source: Facial plastic surgery & aesthetic medicine [Facial Plast Surg Aesthet Med] 2023 May-Jun; Vol. 25 (3), pp. 250-257. Date of Electronic Publication: 2022 Nov 03.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101757922 Publication Model: Print-Electronic

Record details

A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects.

• Authors : Kaur S; Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India.; Singh D

Subjects: Liposomes*/Liposomes*/Liposomes*/chemistry ; Phospholipids*/Phospholipids*/Phospholipids*/chemistry; Drug Delivery Systems

• Source: Assay and drug development technologies [Assay Drug Dev Technol] 2023 Feb-Mar; Vol. 21 (2), pp. 48-64. Date of Electronic Publication: 2023 Feb 28.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

Preparation and Optimization of Liposome Containing Thermosensitive In Situ Nasal Hydrogel System for Brain Delivery of Sumatriptan Succinate.

• Authors : Mathure D; Bharati Vidyappeth's Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India.; Sutar AD

Subjects: Liposomes* ; Sumatriptan*/Sumatriptan*/Sumatriptan*/pharmacokinetics; Hydrogels/Hydrogels/Hydrogels/metabolism

• Source: Assay and drug development technologies [Assay Drug Dev Technol] 2023 Jan; Vol. 21 (1), pp. 3-16. Date of Electronic Publication: 2022 Dec 22.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

Liposomal Bupivacaine Injection in Nuss Procedure Allows Narcotic Avoidance and Improved Outcomes.

• Authors : Jeziorczak PM; OSF Healthcare-Children's Hospital of Illinois, Peoria, Illinois, USA.; Department of Surgery, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.

Subjects: Bupivacaine* ; Liposomes*; Adolescent

• Source: Journal of laparoendoscopic & advanced surgical techniques. Part A [J Laparoendosc Adv Surg Tech A] 2021 Dec; Vol. 31 (12), pp. 1384-1388. Date of Electronic Publication: 2021 Nov Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9706293 Publication Model: Print-Electronic

Record details

High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial.

• Authors : Schiller GJ; 1 Department of Hematology, Oncology, David Geffen School of Medicine at University of California Los Angeles , Los Angeles, California.; Damon LE

Subjects: Injections/Injections/Injections/*methods ; Liposomes/Liposomes/Liposomes/*therapeutic use ; Philadelphia Chromosome/Philadelphia Chromosome/Philadelphia Chromosome/*drug effects

• Source: Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2018 Oct; Vol. 7 (5), pp. 546-552. Date of Electronic Publication: 2018 Sep 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101543508 Publication Model: Print-Electronic

Record details

Enhanced transfection efficiency of human embryonic stem cells by the incorporation of DNA liposomes in extracellular matrix.

• Authors : Villa-Diaz LG; Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48109-1078, USA.; Garcia-Perez JL

Subjects: DNA*/DNA*/DNA*/chemistry ; DNA*/DNA*/DNA*/metabolism ; Embryonic Stem Cells*/Embryonic Stem Cells*/Embryonic Stem Cells*/metabolism

• Source: Stem cells and development [Stem Cells Dev] 2010 Dec; Vol. 19 (12), pp. 1949-57. Date of Electronic Publication: 2010 Sep 29.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101197107 Publication Model: Print-Electronic

Record details

Comparing the enhancement efficiency between liposomes and microbubbles for insulin pulmonary absorption.

• Authors : Xu YY; Wenzhou Medical College, Wenzhou, Zhejiang Province, China.; Lu CT

Subjects: Liposomes* ; Microbubbles*; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*pharmacokinetics

• Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2011 Jul; Vol. 13 (7), pp. 759-65. Date of Electronic Publication: 2011 Apr 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury.

• Authors : Hoesel LM; Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109-0602, USA.; Flierl MA

Subjects: Antioxidants*/Antioxidants*/Antioxidants*/chemistry ; Antioxidants*/Antioxidants*/Antioxidants*/metabolism ; Antioxidants*/Antioxidants*/Antioxidants*/therapeutic use

• Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2008 May; Vol. 10 (5), pp. 973-81.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print Cited

Record details

Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines.

• Authors : Miao L; 1 Lab of Genetics and Molecular Biology, Northeast Forestry University , Harbin, China .; 2 Department of Vaccine Research, Changchun Institute of Biological Products Co., Ltd , Changchun, China .

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*pharmacology ; Liposomes/Liposomes/Liposomes/*pharmacology ; Rabies/Rabies/Rabies/*mortality

• Source: Viral immunology [Viral Immunol] 2017 Dec; Vol. 30 (10), pp. 727-733. Date of Electronic Publication: 2017 Sep 27.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 8801552 Publication Model: Print-Electronic

Record details

Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in mice.

• Authors : Sant VP; Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Mumbai, India.; Nagarsenker MS

Subjects: Etoposide/Etoposide/Etoposide/*administration & dosage ; Etoposide/Etoposide/Etoposide/*therapeutic use ; Liposomes/Liposomes/Liposomes/*chemistry

• Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2003 Oct; Vol. 18 (5), pp. 811-7.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:

Record details

Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes.

• Authors : Cortesi R; Department of Pharmaceutical Sciences, University of Ferrara, Italy.; Esposito E

Subjects: DNA/DNA/DNA/*chemistry ; Liposomes/Liposomes/Liposomes/*chemistry; Binding Sites

• Source: Antisense & nucleic acid drug development [Antisense Nucleic Acid Drug Dev] 2000 Jun; Vol. 10 (3), pp. 205-15.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9606142 Publication Model: Print Cited Medium:

Record details

Identification of a Nucleoporin358-Specific RNA Aptamer for Use as a Nucleus-Targeting Liposomal Delivery System.

• Authors : Shrivastava G; 1 Laboratory of Innovative Nanomedicine, Faculty of Pharmaceutical Sciences, Hokkaido University , Sapporo, Japan .; Hyodo M

Subjects: Drug Delivery Systems* ; SELEX Aptamer Technique*; Cell Nucleus/Cell Nucleus/Cell Nucleus/*metabolism

• Source: Nucleic acid therapeutics [Nucleic Acid Ther] 2016 Oct; Vol. 26 (5), pp. 286-298. Date of Electronic Publication: 2016 Aug 22.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic

Record details

Magnetic separation of cells in coculture systems using magnetite cationic liposomes.

• Authors : Ito A; Department of Chemical Engineering, Faculty of Engineering, Kyushu University, Fukuoka 819-0395, Japan.; Jitsunobu H

Subjects: Biocompatible Materials/Biocompatible Materials/Biocompatible Materials/*chemistry ; Coculture Techniques/Coculture Techniques/Coculture Techniques/*methods ; Ferrosoferric Oxide/Ferrosoferric Oxide/Ferrosoferric Oxide/*chemistry

• Source: Tissue engineering. Part C, Methods [Tissue Eng Part C Methods] 2009 Sep; Vol. 15 (3), pp. 413-23.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101466663 Publication Model: Print Cited

Record details

Magnetic concentration of a retroviral vector using magnetite cationic liposomes.

• Authors : Ito A; Department of Chemical Engineering, Faculty of Engineering, Kyushu University , Nishi-ku, Fukuoka, Japan .; Takahashi T

Subjects: Magnetics*; Ferrosoferric Oxide/Ferrosoferric Oxide/Ferrosoferric Oxide/*chemistry ; Genetic Vectors/Genetic Vectors/Genetic Vectors/*genetics

• Source: Tissue engineering. Part C, Methods [Tissue Eng Part C Methods] 2009 Mar; Vol. 15 (1), pp. 57-64.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101466663 Publication Model: Print Cited

Record details

Carboxymethylated (1 --> 3)-beta-D-glucan protects liposomes against ultraviolet light-induced lipid peroxidation.

• Authors : Schronerová K; Department of Biophysics, Comenius University, Bratislava, Slovakia.; Babincová M

Subjects: Ultraviolet Rays*; Antioxidants/Antioxidants/Antioxidants/*pharmacology ; Glucans/Glucans/Glucans/*pharmacology

• Source: Journal of medicinal food [J Med Food] 2007 Mar; Vol. 10 (1), pp. 189-93.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9812512 Publication Model: Print Cited Medium:

Record details

Lanthanide-loaded liposomes for multimodality imaging and therapy.

• Authors : Zielhuis SW; Department of Nuclear Medicine, University Medical Center, Utrecht, The Netherlands.; Seppenwoolde JH

Subjects: Lanthanoid Series Elements/Lanthanoid Series Elements/Lanthanoid Series Elements/*administration & dosage ; Liposomes/Liposomes/Liposomes/*administration & dosage ; Magnetic Resonance Imaging/Magnetic Resonance Imaging/Magnetic Resonance Imaging/*methods

• Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2006 Oct; Vol. 21 (5), pp. 520-7.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:

Record details

Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol.

• Authors : Cao A; Laboratoire de Chimie Structurale et Spectroscopie Biomoléculaire, CNRS URA 1430, UFR de Médecine, Université Paris XIII, Bobigny, France.; Briane D

Subjects: Cholesterol/Cholesterol/Cholesterol/*metabolism ; DNA/DNA/DNA/*administration & dosage ; DNA/DNA/DNA/*metabolism

• Source: Antisense & nucleic acid drug development [Antisense Nucleic Acid Drug Dev] 2000 Oct; Vol. 10 (5), pp. 369-80.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9606142 Publication Model: Print Cited Medium:

Record details

Liposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration.

• Authors : Kim DH; 1 Division of Applied Life Science, College of Veterinary Medicine, Gyeongsang National University , Jinju, Republic of Korea.; Moon C

Subjects: CpG Islands* ; Liposomes*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage

• Source: Nucleic acid therapeutics [Nucleic Acid Ther] 2015 Apr; Vol. 25 (2), pp. 95-102. Date of Electronic Publication: 2015 Feb 18.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic

Record details

Liposome-Mediated Drug Delivery in Larval Zebrafish to Manipulate Macrophage Function.

• Authors : Wu Z; 1 School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Koh B

Subjects: Zebrafish*; Drug Delivery Systems/Drug Delivery Systems/Drug Delivery Systems/*veterinary ; Epoxy Compounds/Epoxy Compounds/Epoxy Compounds/*chemistry

• Source: Zebrafish [Zebrafish] 2019 Apr; Vol. 16 (2), pp. 171-181. Date of Electronic Publication: 2019 Feb 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101225070 Publication Model: Print-Electronic

Record details

Cationic liposomes enhance cellular/nuclear localization of 99mTc-antisense oligonucleotides in target tumor cells.

• Authors : Zhang YM; Division of Nuclear Medicine, Department of Radiology, University of Massachusetts Medical School, Worcester, MA 0165, USA.; Rusckowski M

Subjects: Gene Targeting/Gene Targeting/Gene Targeting/*methods ; Liposomes/Liposomes/Liposomes/*administration & dosage ; Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/*administration & dosage

• Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2001 Oct; Vol. 16 (5), pp. 411-9.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:

Record details

Liposomal Delivery of Demineralized Dentin Matrix for Dental Tissue Regeneration.

• Authors : Melling GE; 1 Department of Oral and Biomedical Sciences, School of Dentistry, Cardiff University , Cardiff, United Kingdom .; 2 Department of Biological and Medical Sciences, Oxford Brookes University , Oxford, United Kingdom .

Subjects: Regeneration*; Dental Pulp/Dental Pulp/Dental Pulp/*physiology ; Dentin/Dentin/Dentin/*chemistry

• Source: Tissue engineering. Part A [Tissue Eng Part A] 2018 Jul; Vol. 24 (13-14), pp. 1057-1065. Date of Electronic Publication: 2018 Feb 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101466659 Publication Model: Print-Electronic

Record details

Astragalus Saponins and Liposome Constitute an Efficacious Adjuvant Formulation for Cancer Vaccines.

• Authors : Zhang XP; 1 Institute of Integrated Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine , Lanzhou, China .; Li YD

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*chemistry ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*chemistry ; Liposomes/Liposomes/Liposomes/*chemistry

• Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2018 Feb; Vol. 33 (1), pp. 25-31.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:

Record details

Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramide.

• Authors : Salli U; Department of Pharmacology, Pennsylvania State University, College of Medicine, Hershey, Pennsylvania 17033-0850, USA.; Fox TE

Subjects: Cell Differentiation/Cell Differentiation/Cell Differentiation/*physiology ; Ceramides/Ceramides/Ceramides/*pharmacology ; Embryonic Stem Cells/Embryonic Stem Cells/Embryonic Stem Cells/*drug effects

• Source: Stem cells and development [Stem Cells Dev] 2009 Jan-Feb; Vol. 18 (1), pp. 55-65.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101197107 Publication Model: Print Cited

Record details

Development and effects of immunoliposomes carrying an antisense oligonucleotide against DHFR RNA and directed toward human breast cancer cells overexpressing HER2.

• Authors : Rodríguez M; Department of Biochemistry, School of Pharmacy, University of Barcelona, Spain.; Coma S

Subjects: Liposomes*; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*genetics ; Oligonucleotides, Antisense/Oligonucleotides, Antisense/Oligonucleotides, Antisense/*administration & dosage

• Source: Antisense & nucleic acid drug development [Antisense Nucleic Acid Drug Dev] 2002 Oct; Vol. 12 (5), pp. 311-25.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9606142 Publication Model: Print Cited Medium:

Record details

Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA.

• Authors : McCluskie MJ; Loeb Research Institute, Ottawa, Canada.; Chu Y

Subjects: Gene Transfer Techniques*; DNA/DNA/DNA/*metabolism ; Liposomes/Liposomes/Liposomes/*metabolism

• Source: Antisense & nucleic acid drug development [Antisense Nucleic Acid Drug Dev] 1998 Oct; Vol. 8 (5), pp. 401-14.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9606142 Publication Model: Print Cited Medium:

Record details

Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants.

• Authors : Joshi SS; Hepatitis Division, National Institute of Virology , Pune, India .; Arankalle VA

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*administration & dosage ; Alum Compounds/Alum Compounds/Alum Compounds/*administration & dosage ; Epitopes/Epitopes/Epitopes/*immunology

• Source: Viral immunology [Viral Immunol] 2016 Jul-Aug; Vol. 29 (6), pp. 350-60. Date of Electronic Publication: 2016 Jun 10.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 8801552 Publication Model: Print-Electronic

Record details

Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells: a word of caution.

• Authors : Maus U; Department of Internal Medicine, Justus-Liebig-University, Giessen, Germany.; Rosseau S

Subjects: Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*metabolism ; Liposomes/Liposomes/Liposomes/*pharmacology ; Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/*metabolism

• Source: Antisense & nucleic acid drug development [Antisense Nucleic Acid Drug Dev] 1999 Feb; Vol. 9 (1), pp. 71-80.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9606142 Publication Model: Print Cited Medium:

Record details

Evaluation of two cationic delivery systems for siRNA.

• Authors : Yadava P; Department of Pharmaceutics, University of Florida, Gainesville, FL 32610, USA.; Roura D

Subjects: RNA Interference*; Liposomes/Liposomes/Liposomes/*metabolism ; Polyethyleneimine/Polyethyleneimine/Polyethyleneimine/*metabolism

• Source: Oligonucleotides [Oligonucleotides] 2007 Summer; Vol. 17 (2), pp. 213-22.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin.

• Authors : Wittgen BP; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.; Kunst PW

Subjects: Nebulizers and Vaporizers* ; Ventilation*; Air Pollution, Indoor/Air Pollution, Indoor/Air Pollution, Indoor/*prevention & control

• Source: Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine [J Aerosol Med] 2006 Fall; Vol. 19 (3), pp. 385-91.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 8809251 Publication Model: Print Cited Medium:

Record details

Nanoliposomes Embedded Nanocochleates for Codelivery of Artemether and Lumefantrine: An In Vitro and In Vivo Study.

• Authors : Mathure D; Department of Pharmaceutics, Bharati Vidyapeeth's Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India.; Sonawane P

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Malaria*/Malaria*/Malaria*/drug therapy ; Malaria*/Malaria*/Malaria*/parasitology

• Source: Assay and drug development technologies [Assay Drug Dev Technol] 2024 Feb-Mar; Vol. 22 (2), pp. 63-72. Date of Electronic Publication: 2024 Jan 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma.

• Authors : Vikram; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.; Kumar S

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy

• Source: Assay and drug development technologies [Assay Drug Dev Technol] 2024 Feb-Mar; Vol. 22 (2), pp. 73-85. Date of Electronic Publication: 2024 Jan 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

Cytotoxic Evaluation in HaCaT Cells of the Pa.7 Bacteriophage from Cutibacterium ( Propionibacterium ) acnes , Free and Encapsulated Within Liposomes.

• Authors : Torres Di Bello D; Microbiology Research Center-CIMIC, Department of Biological Sciences, Universidad de los Andes, Bogotá, Colombia.; Narváez DM

• Source: PHAGE (New Rochelle, N.Y.) [Phage (New Rochelle)] 2023 Mar 01; Vol. 4 (1), pp. 26-34. Date of Electronic Publication: 2023 Mar 17.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101768955 Publication Model: Print-Electronic

Record details

Lungs, Liposomes, Libraries, and Likely Interactions Between Phages and Eukaryotic Cells.

• Authors : Clokie M; Centre for Phage Research, Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.; Sicheritz-Pontén T

• Source: PHAGE (New Rochelle, N.Y.) [Phage (New Rochelle)] 2023 Mar 01; Vol. 4 (1), pp. 1-2. Date of Electronic Publication: 2023 Mar 17.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101768955 Publication Model: Print-Electronic

Record details

α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line.

• Authors : Sandal P; Department of Pharmaceutics, ISF College of Pharmacy, Moga, India.; Patel P

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy; Humans

• Source: Assay and drug development technologies [Assay Drug Dev Technol] 2023 Nov-Dec; Vol. 21 (8), pp. 345-356. Date of Electronic Publication: 2023 Nov 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

Aquatic Ferrous Solutions of Prebiotic Mineral Salts as Strong UV Protectants and Possible Loci of Life Origin.

• Authors : Subbotin V; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA.; Fiksel G

Subjects: Ultraviolet Rays*/Ultraviolet Rays*/Ultraviolet Rays*/adverse effects ; Salts*; Humans

• Source: Astrobiology [Astrobiology] 2023 Jul; Vol. 23 (7), pp. 741-745. Date of Electronic Publication: 2023 Jun 16.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101088083 Publication Model: Print-Electronic

Record details

New Boron Delivery Agents.

• Authors : Beck-Sickinger AG; Faculty of Life Sciences, Institute of Biochemistry, Leipzig University, Leipzig, Germany.; Becker DP

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/diagnostic imaging ; Neoplasms*/Neoplasms*/Neoplasms*/radiotherapy ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

• Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Apr; Vol. 38 (3), pp. 160-172. Date of Electronic Publication: 2022 Nov 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

Resveratrol-Loaded Dipalmitoylphosphatidylcholine Liposomal Large Porous Microparticle Inhalations for the Treatment of Bacterial Pneumonia Caused by Acinetobacter baumannii .

• Authors : Yu Z; Department of Laboratory, Institute of Clinical Pharmacy and Pharmacology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China.; Wu T

Subjects: Acinetobacter baumannii* ; Pneumonia, Bacterial*/Pneumonia, Bacterial*/Pneumonia, Bacterial*/drug therapy ; Pulmonary Surfactants*

• Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2023 Feb; Vol. 36 (1), pp. 2-11. Date of Electronic Publication: 2023 Jan 24.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print-Electronic

Record details

What Do COVID-19 Vaccines Tell Us About Nucleic Acid Delivery In Vivo ?

• Authors : Hadjiargyrou M; Department of Biological and Chemical Sciences, New York Institute of Technology, Old Westbury, New York, USA.

Subjects: Gene Transfer Techniques*; COVID-19/COVID-19/COVID-19/*prevention & control ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*administration & dosage

• Source: Nucleic acid therapeutics [Nucleic Acid Ther] 2021 Oct; Vol. 31 (5), pp. 321-323. Date of Electronic Publication: 2021 May 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic

Record details

Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.

• Authors : Cipolla D; 1 Department of Pharmacuetical Sciences, Aradigm Inc. , Hayward, California.; 2 Faculty of Pharmacy, University of Sydney , Sydney, New South Wales, Australia .

Subjects: Nanoparticles*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*chemistry ; Ciprofloxacin/Ciprofloxacin/Ciprofloxacin/*chemistry

• Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2015 Dec; Vol. 28 (6), pp. 411-22. Date of Electronic Publication: 2015 Oct 15.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print-Electronic

Record details

Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole - Resistant Clinical Isolates of Candida albicans , Biological Activity and ERG11, CDR1, and CDR2 Gene Expression.

• Authors : Hassanpour P; Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.; Hamishehkar H

Subjects: Candida albicans*/Candida albicans*/Candida albicans*/genetics ; Fluconazole*/Fluconazole*/Fluconazole*/pharmacology; Antifungal Agents/Antifungal Agents/Antifungal Agents/pharmacology

• Source: Assay and drug development technologies [Assay Drug Dev Technol] 2021 Oct; Vol. 19 (7), pp. 453-462. Date of Electronic Publication: 2021 Aug 25.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery.

• Authors : Berger AG; Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Harvard-MIT Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Subjects: Genetic Therapy*; Biocompatible Materials/Biocompatible Materials/Biocompatible Materials/*pharmacology ; Diabetic Foot/Diabetic Foot/Diabetic Foot/*therapy

• Source: Advances in wound care [Adv Wound Care (New Rochelle)] 2021 Sep; Vol. 10 (9), pp. 503-528. Date of Electronic Publication: 2020 Jul 07.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101590593 Publication Model: Print-Electronic

Record details

Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.

• Authors : Swaminathan J; 1 School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Panoz Institute , Dublin 2, Ireland .; Gobbo OL

Subjects: Drug Carriers*; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*administration & dosage ; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*pharmacokinetics

• Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2014 Feb; Vol. 27 (1), pp. 1-11. Date of Electronic Publication: 2013 Nov 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print-Electronic

Record details

Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.

• Authors : Gaspar MM; School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.; Radomska A

Subjects: Drug Delivery Systems*; Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/*pharmacology ; Doxorubicin/Doxorubicin/Doxorubicin/*pharmacology

• Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2012 Dec; Vol. 25 (6), pp. 310-8. Date of Electronic Publication: 2012 Aug 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print-Electronic

Record details

The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin.

• Authors : Shirzad M; 1Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.; Jamehbozorgi S

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Cisplatin/Cisplatin/Cisplatin/*pharmacology ; Nanoparticles/Nanoparticles/Nanoparticles/*chemistry

• Source: Assay and drug development technologies [Assay Drug Dev Technol] 2019 Jul; Vol. 17 (5), pp. 231-239. Date of Electronic Publication: 2019 May 13.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic

Record details

Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.

• Authors : Lin YY; Biomedical Imaging and Radiological Sciences, National Yang-Ming University , Taipei, Taiwan, Republic of China.; Li JJ

Subjects: Indium Radioisotopes*/Indium Radioisotopes*/Indium Radioisotopes*/pharmacokinetics; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*diagnostic imaging ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*metabolism

• Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2009 Aug; Vol. 24 (4), pp. 453-60.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium:

Record details

Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.

• Authors : Taetz S; UMR CNRS 8612, Université Paris Sud 11, Châtenay-Malabry, France.; Bochot A

Subjects: Fatty Acids, Monounsaturated/Fatty Acids, Monounsaturated/Fatty Acids, Monounsaturated/*chemistry ; Hyaluronic Acid/Hyaluronic Acid/Hyaluronic Acid/*chemistry ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*therapy

• Source: Oligonucleotides [Oligonucleotides] 2009 Jun; Vol. 19 (2), pp. 103-16.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.

• Authors : Weers J; Transave, Inc., Monmouth Junction, New Jersey, USA.; Metzheiser B

Subjects: Amikacin/Amikacin/Amikacin/*administration & dosage ; Amikacin/Amikacin/Amikacin/*pharmacokinetics ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage

• Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2009 Jun; Vol. 22 (2), pp. 131-8.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print Cited

Record details